Clinical trial
A CLINICAL STUDY OF THE MeMed BV® TEST TO DISTINGUISH BETWEEN BACTERIAL AND VIRAL INFECTIONS AND LIMIT GUT COLONIZATION BY MULTIDRUG RESISTANT MICROORGANISMS
NCT05897801 is registered in ClinicalTrials.gov with Hellenic Institute for the Study of Sepsis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A CLINICAL STUDY OF THE MeMed BV® TEST TO DISTINGUISH BETWEEN BACTERIAL AND VIRAL INFECTIONS AND LIMIT GUT COLONIZATION BY MULTIDRUG RESISTANT MICROORGANISMS
- Lead sponsor
- Hellenic Institute for the Study of Sepsis
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 29, 2023
- Completion date
- January 31, 2024
- Enrollment
- 230 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
bacterial infections, multi-antibiotic resistance, respiratory tract infections, viral infection